The Future of Pathology: Hyland's Digital Revolution in Healthcare Imaging
The Future of Pathology: Hyland's Digital Revolution in Healthcare Imaging
The healthcare industry has undergone significant modernization in fields like radiology and cardiology over the last decade. Yet, pathology has lagged behind, remaining predominantly analog. A staggering 90% of pathology laboratories still rely on glass slides for diagnostic work, even as workload demands have surged by 42%. This discrepancy has resulted in unacceptable delays in patient diagnoses, costing healthcare systems both valuable time and substantial financial resources.
Addressing the Challenge
Hyland is changing the narrative with the launch of Hyland Digital Pathology, powered by Tribun Health. This enterprise-grade digital pathology solution marks a pivotal step towards resolving the clinical, operational, and architectural fragmentation that has kept pathology disconnected from the broad digital transformation of healthcare. By integrating various imaging specialties—radiology, cardiology, pathology, and ophthalmology—within a single, managed platform, Hyland eliminates the need for creating additional departmental silos.
Vinitha Ramnathan, Senior Vice President and General Manager of Health Product Management at Hyland, emphasizes, "Pathology must be at the core of any enterprise imaging strategy. With Hyland Digital Pathology, we empower healthcare systems to move beyond isolated workflows, connecting pathology with radiology and cardiology on a scalable and regulated imaging platform. This connects pathologists with essential diagnostic information, enabling better clinical decisions."
Breaking Down Barriers
The Hyland Digital Pathology solution is meticulously designed for primary diagnostics and is FDA-approved, Health Canada-certified, and CE-marked. It overcomes the last major barrier to widespread clinical adoption in pathology. Rather than forcing pathologists to adapt to a generic imaging platform, it allows them to retain their trusted diagnostic workflows, enabling faster adoption and immediate clinical confidence.
Jean-François Pomerol, CEO of Tribun Health, argues, "Digital pathology cannot scale as an isolated departmental project. By integrating CaloPix® into Hyland's enterprise imaging ecosystem, we create a practical pathway for healthcare providers to modernize pathology while maintaining specialized workflows and regulatory compliance."
Key Features of Hyland Digital Pathology
The key design principles of Hyland Digital Pathology emphasize openness and interoperability. Its components include:
1. CaloPix Image Management System (IMS): A native pathology workflow engine that delivers primary diagnostic capabilities, case management, and AI-assisted analysis within a familiar interface. This speeds the transition from glass to digital diagnostics.
2. Medical Imaging Integration: With Acuo VNA and NilRead, the solution expands vendor-neutral archiving and universal visualization across various specialties, ensuring seamless data flow across multidisciplinary workflows without proprietary barriers.
3. AI-Ready and Interoperable: This framework supports open AI without segmenting the existing infrastructure with point solutions, backed by DICOM standardization, LIS and EMR connectivity, and flexible deployment models.
By extending existing capabilities, Hyland Digital Pathology integrates seamlessly into healthcare imaging without requiring a complete overhaul of existing systems.
Clinical Reliability and Cost Benefits
Combining the clinical credibility of Tribun Health with Hyland’s expansive medical imaging capabilities yields a platform that is already managing millions of imaging examinations across radiology, cardiology, and specialized areas in healthcare systems globally.
For healthcare institutions, Hyland Digital Pathology offers compelling business advantages:
1. Faster Clinical Decisions: It enables pathologists to move quickly from glass slides to digital formats while maintaining reliable workflows, enhancing diagnostic timeliness.
2. Increased Pathologist Efficiency: By reducing administrative burdens, this solution supports telepathology and enables more flexible working models, addressing burnout amid a growing pathologist shortage.
3. Cost Control: Integrating pathology into a broader medical imaging strategy mitigates redundant archiving costs, decreases governance overhead, and facilitates intelligent data prioritization, paving the way for a truly integrated healthcare system.
In summary, these improvements in speed, collaboration, and cost management make Hyland Digital Pathology not just a clinical upgrade, but a sound commercial investment. For healthcare systems poised to innovate pathology and leverage the clinical value of an integrated diagnostic record, Hyland Digital Pathology is the solution the market has been eagerly awaiting.
Hyland will demonstrate its Digital Pathology solution at RSNA 2026 at booth #1322 from November 29 to December 2 in Chicago. For more details about their platform and solutions, visit Hyland.com.
About Hyland
Hyland is a leader in content intelligence and automation, helping organizations transform enterprise content into governed intelligence that accelerates decision-making and business performance. Used by thousands of organizations worldwide, including many Fortune 100 companies, Hyland's open platform harnesses AI to convert content, data, and processes into reliable context, allowing users, applications, and agents to automate tasks effectively.
For further information, please check Hyland.com.
About Tribun Health
Tribun Health stands as a global leader in digital pathology, offering the award-winning Best in KLAS CaloPix® platform, which is CE-marked, Health Canada-approved, and FDA-authorized for clinical use. Their pathology solutions aim to enhance workflow efficiency, diagnostic accuracy, and patient outcomes. Their mission is clear: to ensure every cancer patient receives timely and informed diagnoses, because every minute counts. Through cutting-edge innovations, Tribun Health is shaping the future of cancer treatment. For additional insights, visit Tribun.Health.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.